PeptiStar Inc. (Headquarter: Osaka, Settsu, herein PS) announced today that PS held a completion ceremony on 10th July, with many guests representing Osaka prefecture, Settsu city, customers, shareholders, constructors, and so on. The construction of HQ R&D bu...

PeptiStar Inc. announces that at the company’s Annual General Meeting of Shareholders, followed by Extraordinary Board Meeting held on 11th of June, 2019, Yutaka Kameyama, Ph.D., was appointed as new CEO & President and assumed his new position on the same...

The construction of the HQ R&D Bldg. has been successfully completed. After completion of validation works, we are going to start our R&D business like non-GMP manufacturing/process development etc from late June onwards. 本社研究棟の工事が完了し、定礎式を行いました。 種々のバリデ...

We will exhibit at TIDES: Oligonucleotide and Peptide Therapeutics,held on 20th-23rd of May 2019 in San Diego, US. Booth No. is 818. 米国サンディエゴで2019年5月20日から23日にかけて開催されるTIDES: Oligonucleotide and Peptide Therapeuticに出展いたします（ブース番号：818）

We will run a booth at CPhl World wide 2018, which is held on 9th - 11th October 2018 in Madrid, Spain. Booth No. is 9H70. スペイン・マドリードで、2018年10月9日から11日に開催されるCPhI Worldwide 2018に出展いたします（ブース番号：9H70)。 https://www.cphi.com/europe/

On 25th May 2018, we held a groundbreaking and Jichinsai ceremony for our new main plant. It's now under construction to start operations in autumn of 2019. 本社工場 新築工事の地鎮祭と着工式を2018年5月28日に行いました。現在、2019年秋の稼動に向けて工事中です。

On 25th September 2018, we have released our website. 2018年9月25日当社のWEBサイトをリリースしました。